{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:45:53Z","timestamp":1790214353166,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["25461273"],"award-info":[{"award-number":["25461273"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jneuroim.2016.10.011","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T08:01:12Z","timestamp":1478678472000},"page":"30-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Caveolin-3 is aberrantly expressed in skeletal muscle cells in myasthenia gravis"],"prefix":"10.1016","volume":"301","author":[{"given":"Kazuo","family":"Iwasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2016.10.011_bb0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2044-5040-1-26","article-title":"T-tubule biogenesis and triad formation in skeletal muscle and implication in human diseases","volume":"1","author":"Al-Qusairi","year":"2011","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00441-014-1930-9","article-title":"Syncytin-1 in differentiating human myoblasts: relationship to caveolin-3 and myogenin","volume":"357","author":"Bjerregard","year":"2014","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0015","doi-asserted-by":"crossref","first-page":"15894","DOI":"10.1074\/jbc.M109.009589","article-title":"Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin","volume":"284","author":"Cai","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1471-4914(01)02105-0","article-title":"Caveolae and caveolin-3 in muscular dystrophy","volume":"7","author":"Galbiati","year":"2001","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1091\/mbc.e09-05-0381","article-title":"Caveolin-3 promotes nicotinic acetylcholine receptor clustering and regulates neuromuscular junction activity","volume":"21","author":"Hezel","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jneuroim.2010.04.017","article-title":"Up-regulation of MHC class I and class II in the skeletal muscles of myasthenia gravis","volume":"225","author":"Iwasa","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0035","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2010.11.015","article-title":"Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies","volume":"21","author":"Lo","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0040","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3109\/08916934.2015.1030614","article-title":"Complicating autoimmune diseases in myasthenia gravis: a review","volume":"48","author":"Nacu","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0165-5728(02)00026-7","article-title":"Regulation of class I MHC expression in skeletal muscle: deleterious effect of aberrant expression on myogenesis","volume":"125","author":"Pavlath","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0050","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1091\/mbc.e09-02-0175","article-title":"Focal adhesion kinase signaling regulates the expression of caveolin 3 and beta1 integrin, genes essential for normal myoblast fusion","volume":"20","author":"Quach","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0055","doi-asserted-by":"crossref","first-page":"547-350","DOI":"10.1006\/bbrc.1999.1055","article-title":"Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy","volume":"261","author":"Repetto","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00246-010-9881-8","article-title":"Role of caveolae in cardiac protection","volume":"32","author":"Roth","year":"2011","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2009.01.002","article-title":"Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two","volume":"19","author":"Schoser","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0070","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1074\/jbc.271.25.15160","article-title":"Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins","volume":"271","author":"Song","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0075","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/QAD.0b013e32833a6114","article-title":"Resveratrol protects against protease inhibitor-induced reactive oxygen species production, reticulum stress and lipid raft perturbation","volume":"24","author":"Touzet","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0854.2003.00164.x","article-title":"Membrane traffic in skeletal muscle","volume":"5","author":"Towler","year":"2004","journal-title":"Traffic"},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0085","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/ALN.0b013e3181d3d624","article-title":"Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection","volume":"112","author":"Tsutsumi","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0090","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1091\/mbc.e03-03-0161","article-title":"Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C","volume":"14","author":"Volonte","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0095","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1212\/WNL.62.4.538","article-title":"Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases","volume":"62","author":"Woodman","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.10.011_bb0100","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1523\/JNEUROSCI.2807-05.2006","article-title":"Lipid rafts serve as a signaling platform for nicotinic acetylcholine receptor clustering","volume":"26","author":"Zhu","year":"2006","journal-title":"J. Neurosci."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816303782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816303782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:28:50Z","timestamp":1759048130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816303782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":20,"alternative-id":["S0165572816303782"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.10.011","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caveolin-3 is aberrantly expressed in skeletal muscle cells in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}